While vaccines such as Uromune may not be an accessible or perfect solution for everyone, they offer real hope for people tired of recurring UTIs and endless rounds of antibiotics.
Articles on Health
Displaying 1001 - 1020 of 2446 articles
England’s opt-out organ donation system aimed to increase the number of donations. But new research reveals the policy has instead led to confusion, complications and a drop in donation rates.
Here’s how the symptoms differ – and what to do about them.
One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a suitable vaccine.
Marburg virus has killed 12 people in the latest outbreak, but a new vaccine is now to hand.
COVID antivirals are recommended for people aged over 70 and those at risk of severe illness. But many older Australians are missing out. Here’s why – and how to fix this problem.
ADHD is the most diagnosed childhood neurological disorder, but there have been inconsistencies around who is diagnosed and prescribed medication. New prescribing guidelines aim to change this.
XEC is a recombinant variant, meaning it’s a hybrid of two previously existing variants. Genomic data suggests it’s making up around 5% of cases in Australia – but it may grow.
Iron supplements aren’t the only solution
Our research found clarity and consistency of information were key features of effective public health communication throughout the COVID pandemic.
Patents for a drug related to Ozempic have expired, so pharmaceutical companies are working to develop ‘generic’ versions. These are likely to be much cheaper. But how do they compare with Ozempic?
In many cases, patients are unable to shop around or make informed decisions about their care due to a lack of information about the true cost and quality of services.
The change is intended to balance access to vapes for adults using them to quit smoking with the need to protect young people from taking up vaping.
Common issues such as hair loss, nausea, skin problems and fatigue can seriously affect patients’ quality of life.
Health leaders, researchers, advocacy groups, companies and the public have saved millions of lives by reducing the consumption of unhealthy products.
Medical services are protected under international law. When they are attacked without any consequences, it sends the message health-care workers and patients are acceptable targets.
The COVID pandemic is ongoing, but scientists are on alert for any pathogen that might lead to another global outbreak of disease.
Half of all GP practices in New Zealand have closed their books to new patients. This means people are going on emergency departments for care – with deadly outcomes when it comes to lung cancer.
For many of us, COVID has become just a bad memory, despite its lasting and mixed legacies. While the media have largely lost interest in COVID, and people are now rather blase about it, the disease is still taking a toll.
A government review into private hospitals has yet to be made public. In the meantime, here’s whether there’s a case for a government bail-out.
Top contributors
-
Senior Lecturer in Pharmacy Practice, Kingston University
-
Senior Lecturer, School of Psychology and Neuroscience, University of Bristol
-
Professor of Community Health and Wellbeing, The University of Queensland
-
Professor of Anatomy, Lancaster University
-
Clinical Trials Director, Department of Endocrinology, RPA Hospital, University of Sydney
-
Professor of Biomedical Sciences, Anglia Ruskin University
-
Program Director of Nutrition and Food Sciences, Accredited Practising Dietitian, University of South Australia
-
Lecturer in Exercise Science, University of South Australia
-
Professor, School of Natural Sciences, Macquarie University
-
Accredited Practising Dietitian and Lecturer, Southern Cross University
-
Associate Professor, Epidemiology, Deakin University
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
-
Professor of Health Economics, The University of Melbourne
-
Associate Professor and Principal Fellow in Urban Risk and Resilience, The University of Melbourne
-
Professorial Fellow, University of Canberra